Eye Care Firm SpyGlass Pharma Soars 50% After $150 Million IPO
SpyGlass Pharma Inc. shares jumped 50% in the biopharmaceutical firm’s trading debut after it raised $150 million in an initial public offering.
By Avalon Pernell · Bloomberg Markets
SpyGlass Pharma Inc. shares jumped 50% in the biopharmaceutical firm’s trading debut after it raised $150 million in an initial public offering.